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Connexin the dots
 
ew dyes 
developed by 
Guido Gaietta, 
Roger Tsien, Mark 
Ellisman (University 
of California at San 
Diego, La Jolla, CA), 
and colleagues allow 
efficient fluorescent 
and electron micros-
copy for studying the 
location, trafficking, 
assembly, and turn-
over of proteins and 
protein complexes.
“We were 
interested in being 
able to go from light 
microscopy to the 
EM level,” says 
Ellisman. “In 
particular, we wanted 
better resolution 
N
New connexin (red) 
is added to the 
outside of existing 
plaques (green).
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than with immunogold labeling.” To do 
so, the group examined FlAsH, a biarsenical 
 
Widening the target for cancer treatment
 
octors treating cancer patients should aggressively target 
the area surrounding a tumor during surgery and radiation 
therapy. That suggestion comes as a result of new studies 
from Timothy Padera, Rakesh K. Jain, and colleagues 
(Harvard Medical School, Boston, MA), who report that 
metastasis occurs through lymphatic vessels in the tumor 
margin and nearby normal tissue.
Cancer cells can metastasize by escaping a tumor 
through either blood or lymphatic vessels. Jain’s group 
questioned whether cancerous cells escape through 
lymphatic vessels within the tumor itself. In various trans-
planted and spontaneous tumors in mice, and in human 
tumors, markers of lymphatic vessels were found within 
the tumors, but functional analysis revealed that these 
vessels were not draining fluid.
Jain suggests that lymphatic vessels in tumors may collapse 
from the high pressure exerted by the rapidly proliferating 
cancer cells. The findings also act as a warning against the 
use of markers alone to identify functioning lymphatic 
vessels in tumors. “A combination of markers as well as 
functional studies will be necessary,” Jain says.
Although lymphatic vessels in the tumor were not functional, 
those in the margin of the mouse tumors were either normal 
in appearance or, in tumors overexpressing VEGF-C, larger 
in diameter than normal vessels. With increased size came 
D
 
derivative of fluorescein. FlAsH binds to 
small amino acid extensions containing the 
sequence C-C-X-X-C-C, which can be 
added to recombinant target proteins. 
Binding of FlAsH causes the ligand to 
emit a strong green fluorescence, and 
binding of ReAsH, a red variant, leads to 
red fluorescence.
ReAsH is the variant that is useful for 
EM, because it can generate singlet 
oxygen upon illumination. Singlet 
oxygen drives localized polymerization of 
the substrate diaminobenzidene (DAB) 
into an insoluble form that can be viewed 
by EM. “Because the fluorescent label 
binds directly to the protein you are 
trying to localize, and the DAB polymer 
deposits directly nearby the fluorophore, 
the resolution is better [than immunogold 
labeling],” says Ellisman. Additionally, 
this technique does not require the 
diffusion of large antibodies into the 
fixed specimens.
The group put their new label to work 
by examining the protein connexin43, 
which multimerizes to form gap 
junctions. Pulse-chase with first FlAsH 
and then ReAsH revealed newer (i.e., 
red) molecules of connexin at the outer 
edge of large clusters of gap junctions 
known as plaques. Green molecules were 
concentrated in the center, indicating 
that older connexins are endocytosed 
from the middle of the plaques. EM 
demonstrated that newly synthesized 
connexins were first sent to nonplaque 
sites on the cell surface before flowing 
to the edge of a plaque.
The team expects there will be many 
uses for the FlAsH-ReAsH system, especially 
in revealing how large complexes, such as 
receptor patches at synapses, are formed. 
“Anyone who has a question about how 
a cell manages the assembly of large 
macromolecular structures of a protein 
should benefit from the use of this system,” 
says Ellisman.
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increased lymphatic metastasis, suggesting that marginal 
lymphatics are sufficient for metastasis. “The larger size 
of these vessels increases the opportunity for cancer cells 
to escape,” says Jain. Thus, radiation therapy should be 
directed at tumor margins in addition to their centers, and 
VEGF-C may provide a good target for drug treatments. 
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Lymphatic vessels (brown) in tumors are not functional.
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